ACT NOW TO PROTECT YOUR
COMPOUNDED BIOIDENTICAL HORMONES!
Action Alert! Write to Congress and the FDA, telling them that patients have a right to choose the medicines right for them, including cBHT.
What is happening? The FDA commissioned a study from the National Academies of Sciences, Engineering, and Medicine (NASEM) on the safety, effectiveness and use of compounded bio-identical hormone therapy (cBHT or cBHRT). The NASEM committee has suggested restricting use of cBHT to patients with allergies to FDA-approved drugs, despite the fact that many FDA-approved therapies may not meet the dosing needs of all patients.
If you take compounded hormones and want to help ensure they remain available, we are asking for your help.
What can I do?
- Write to Congress and the FDA, telling them that patients have a right to choose the medicines right for them, including cBHRT. Click here for an easy to use form.
- Please share your story! We need to collect as many positive stories about cBHRT as possible before the FDA decides to ban these crucial hormones and our quality of life! Please send your testimonial right away to stephanie@mycompoundingsolutions.com and we will share it with congress for you. We appreciate your support!
What if I have questions? Visit ANH-USA for more information and email stephanie@mycompoundingsolutions.com with your questions.
